Flora Enters Crypto Space with Strategic Investments in Ethereum, Solana, Sui and Ripple
Fort Lauderdale, Florida--(Newsfile Corp. - May 5, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") today announced an investment into the cryptocurrency and blockchain sector. As part of this transaction, the Company has established a strategic long-term crypto portfolio anchored by US$1 million in leading...
Pharmaceuticals, Cannabis, Cannabis Cultivator, Cannabis Manufacturer
2025-05-05 8:01 AM EDT | Flora Growth Corp.
Optimi Health Obtains U.S. FDA Drug Establishment Registration
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a manufacturer of GMP-certified MDMA and psilocybin, has received its U.S. FDA Establishment Identifier (FEI) number—a key regulatory step for engaging in FDA filings and compliant supply into...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-05 7:35 AM EDT | Optimi Health Corp.
Kiora Pharmaceuticals Presents In Vivo Preclinical Data at ARVO 2025 Demonstrating the Potential of KIO-104 to Treat Proliferative Vitreoretinopathy
Encinitas, California--(Newsfile Corp. - May 5, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced the results from a preclinical study demonstrating KIO-104 significantly reduced scar formation in an established in vivo model of proliferative vitreoretinopathy (PVR). The findings further support KIO-104 as a promising therapeutic...
Biotechnology, Pharmaceuticals
2025-05-05 7:00 AM EDT | Kiora Pharmaceuticals, Inc.
Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
Toronto, Ontario--(Newsfile Corp. - May 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of small molecules and their formulations, able to be activated by light, radiation, sound and/or other drugs, intended for the...
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-05-05 7:00 AM EDT | Theralase Technologies Inc.
Beyond Medical Technologies Provides Update on 2024 Annual Filings
Vancouver, British Columbia--(Newsfile Corp. - May 2, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announces that its application for a management cease trade order ("MCTO") under National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"), as previously announced...
Technology, Pharmaceuticals, Health
2025-05-02 8:30 AM EDT | Beyond Medical Technologies Inc.
CIA Legacy Awards Recognize Leaders in Canadian Actuarial Profession
Ottawa, Ontario--(Newsfile Corp. - May 1, 2025) - The Canadian Institute of Actuaries (CIA) is proud to recognize the extraordinary contributions of our volunteers, whose commitment helps drive the development and success of the actuarial profession in Canada. Each year, the CIA recognizes volunteers who have reached milestones through the...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-01 1:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires
Les Prix du patrimoine de l'ICA récompensent les chefs de file de la profession actuarielle au Canada
Ottawa, Ontario--(Newsfile Corp. - 1 mai 2025) - L'Institut canadien des actuaires (ICA) est fier de souligner les contributions exceptionnelles de nos bénévoles, dont l'engagement contribue au développement et au succès de la profession actuarielle au Canada. Chaque année, l'ICA reconnaît les étapes importantes qu'ils et elles ont franchies lors...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-01 1:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time
Rehovot, Israel--(Newsfile Corp. - May 1, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the first quarter ended March 31, 2025 after market close on Thursday, May...
Biotechnology, Pharmaceuticals, Health
2025-05-01 8:30 AM EDT | BioHarvest Sciences Inc.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Marlborough, Massachusetts--(Newsfile Corp. - May 1, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-01 7:45 AM EDT | Phio Pharmaceuticals Corp.
Psyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock Split
New York, New York--(Newsfile Corp. - May 1, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced the effective date of its 1-for-7.97 share consolidation (reverse stock split) of the Company's issued and outstanding common shares. At a Special Meeting of Stockholders held on April...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-01 7:30 AM EDT | Psyence Biomedical Ltd.
Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
Northvale, New Jersey--(Newsfile Corp. - April 30, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite's generic version of Percocet® (oxycodone hydrochloride and acetaminophen tablets, USP CII) 5mg/325mg, 7.5mg/325mg and 10mg/325mg tablets. Oxycodone...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-04-30 4:30 PM EDT | Elite Pharmaceuticals, Inc.
NuGen Announces Release of 2024 Annual Financial Results
Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration of therapeutics, announces the release of 2024 Annual Financial Results. Annual Financial Statements Reflect Commercial Ramp UpThe orders announced previously in 2024...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-04-30 4:30 PM EDT | NuGen Medical Devices Inc.
Bachem Annual General Meeting 2025
All proposals of the Board of Directors approved. Dividend of CHF 0.85 per share. ...
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2025-04-30 11:55 AM EDT | Bachem Holding AG
Stellar Global Awards Introduces New Silver Category to Broaden Recognition
Houston, Texas--(Newsfile Corp. - April 30, 2025) - To continue its mission of recognizing innovation, Stellar Global Awards has introduced a new Silver Award category, replacing the previous Platinum levels. This change comes after more than 10 years of success and is aimed at expanding recognition across the industry, responding...
Internet Technology, Pharmaceuticals, Publishing/Informational Services, Health
2025-04-30 10:33 AM EDT | BrandingEx Solutions Pvt Ltd.